Together with the two Managing Partners of Entourage, Dominik M. Aumer and Moritz Haucke, our Management Consultants Dr Ralf Hess and Dr Simon Schulz have published an article on the drug shortage and its causes in the Regulatory Affairs Professionals Society.
From the perspective of a medium-sized generic drug manufacturer, the article analyses the causes of the drug shortage in Germany and the causes of production problems at active ingredient and drug manufacturers. Measures to limit damage in a "broken marketplace" are discussed and in the epilogue, the current COVID 19 pandemic is discussed and a warning is given that medicines and active ingredients from China and India could become scarce due to the disruptions caused by the pandemic.
At the following link you can find the article.